Grace, 49, opened twelve browser tabs about “the injections” and felt more confused than when she started. Here is the honest picture of GLP-1 weight loss in Malta — how it works, who it suits, and the part most adverts skip.
GLP-1 weight loss in Malta uses prescription medications such as semaglutide and tirzepatide that mimic a natural gut hormone to reduce appetite and slow digestion. In supervised clinical trials they produced an average 15–22% body-weight reduction. They require a doctor's assessment, ongoing monitoring and a long-term plan to keep the results.
Medically reviewed by Dr. Zaid Teebi, Medical Consultant (30+ years), Carisma Slimming. Last updated 29 June 2026.
Grace, 49, works in finance in Sliema. Last year she noticed her weight settle around the middle in a way it never had before, even though her meals had not changed. Then a friend mentioned she was “on the injections” and had lost two dress sizes. Grace went home and opened twelve browser tabs. By tab nine she felt more confused than when she started, and quietly judged for even looking.
If that sounds familiar, this matters: using medication for weight is not cheating, and it is not the easy way out. Obesity is classified as a chronic disease by the World Health Organisation. Treating a biological condition with a medical tool is not a moral failing. It is medicine.
This guide walks through what GLP-1 weight loss really involves in Malta — how it works, who it suits, the side effects, and the part most adverts skip. No hype, no shame, just an honest picture so you can decide what is right for your body.
What Are GLP-1 Medications?
GLP-1 stands for glucagon-like peptide-1, a hormone your body already makes when you eat. It tells the brain you are full, slows how fast the stomach empties, and helps regulate blood sugar. GLP-1 weight loss medications are lab-made versions of that same hormone, given as a once-weekly injection.
The two you will hear about most are semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro). Tirzepatide works on two hormone pathways rather than one, which is part of why it tends to produce slightly larger results in trials.
One point worth holding onto from the start: these are prescription-only medicines. They are not supplements, not something to buy online, and not something any responsible clinic will hand over without a full assessment first. If anyone offers them without one, you should be wary of that offer.
How GLP-1 Medications Work
Understanding why something works is the difference between a sales claim and an informed decision, so it is worth a moment on the mechanism.
A GLP-1 medication does three things at once. It slows gastric emptying, so food stays in the stomach longer and you feel full sooner. It acts on the satiety centres in the brain, quieting what many patients describe as “food noise” — the constant background pull toward the next snack. And it prompts the pancreas to release insulin appropriately, steadying blood sugar.
On average, GLP-1 receptor agonists reduce food intake by around a third. That is not willpower. That is biology adjusted at the level where appetite is actually decided.
This is the part that lands hardest for women who have tried everything. You did not fail the salad. Your hunger signalling was working against you the entire time, and no amount of trying harder rewrites a hormone. For women navigating insulin resistance, PCOS or perimenopause, where the metabolic deck is genuinely stacked, this mechanism is often the missing piece a standard diet never addressed. You can read more about that in our guide to medical weight loss in Malta.
Realistic Results: What the Trials Show
In the landmark STEP trials, people taking semaglutide lost an average of around 15% of their body weight over roughly a year of supervised treatment. In the SURMOUNT trials, people on the highest dose of tirzepatide lost an average of around 20%. For context, no previous weight loss drug class came anywhere close to those figures.
But averages hide individuals. Stanford Medicine clinicians note that roughly 10–15% of patients lose very little weight even at the maximum dose. Some lose 30% or more. Most sit somewhere in the middle, with weight loss typically slowing around months four to six and plateauing roughly 12–18 months in.
Results may vary from person to person. Anyone who promises you a specific number on the scale before assessing your biology is selling, not treating. What a medically supervised programme can do is tell you whether you are likely to be a strong responder, and how to support the result so your effort is not wasted.
Who GLP-1 Medication Suits — and Who It Doesn't
GLP-1 is a serious medical treatment, not a cosmetic touch-up, so eligibility is specific.
Following NICE guidance, GLP-1 medication is generally considered for adults with a BMI of 30 or above, or 27 or above when a weight-related condition is present such as type 2 diabetes, prediabetes, high blood pressure or insulin resistance. You may also be a candidate if you experience relentless hunger, regain weight despite consistent effort, or are dealing with hormonal weight gain around perimenopause.
It is not the right tool for everyone. GLP-1 is not appropriate during pregnancy or breastfeeding, or for people with certain thyroid cancer risks. The honest answer to “is this me?” is not on a website — it is in your bloods, your history and your goals. For some women, a body-contouring path such as non-surgical fat reduction is a better fit than medication, and a good clinic will tell you that plainly.
Side Effects and Safety
Is Ozempic safe? Broadly, yes. These medicines have been prescribed for diabetes for well over 15 years and tested in tens of thousands of patients. But “safe” does not mean “without effects,” and you deserve the full list before, not after.
The most common side effects are gastrointestinal: nausea, constipation, diarrhoea and reduced appetite, usually in the first weeks as the dose climbs. For most people these settle. Gradual dose increases, smaller meals, adequate fibre and good hydration all help — one of the practical reasons supervision is worth having.
Rarer but more serious risks include pancreatitis and gallbladder problems. The European Medicines Agency lists the full safety profile, and a responsible clinician walks you through it and monitors for it, rather than reciting a disclaimer and moving on.
A separate safety point worth knowing: only use medication obtained on prescription and dispensed by a licensed pharmacy. Unapproved or compounded “weight loss” products sold outside that system carry real risks and are not the same as a regulated GLP-1 programme.
Why Medical Supervision Matters
“Medically supervised” is a phrase used loosely. A repeat online prescription with no review is not supervision, even if a doctor's name appears somewhere on the form.
Real supervision means a proper assessment before anything is prescribed: bloods, blood pressure, full medical history, current medications and body composition reviewed by a doctor. It means monitoring your metabolic markers throughout, not just your weight. It means someone adjusts the plan when your biology responds differently from what the textbook predicts, and someone you can actually reach when a question comes up at 9pm.
None of that happens in an app or a one-off prescription. The reason supervised programmes get better outcomes is not that the medicine is different. It is the same medicine. It is the monitoring and the real plan built around you.
This is also why GLP-1 works best as one tool inside a structured doctor-supervised weight loss programme rather than a standalone injection. The medication quiets appetite; the programme builds the nutrition, the strength training that protects muscle, and the accountability that carries you on the bad days. Habits persist where motivation does not, and structure is what makes results last. You can see how our GLP-1 medical weight loss programme fits into that bigger picture.
The Part Most Adverts Skip: What Happens When You Stop
If you read one section twice, make it this one.
GLP-1 medications are not, for most people, a short course you take, finish and forget. When the medication stops, the appetite signalling it was adjusting returns to where your biology sets it. A 2026 analysis of more than 9,000 patients found people regained close to two pounds a month after stopping. The STEP 1 trial extension found participants regained about two-thirds of their lost weight within a year of stopping.
That is not a flaw in you. It is how a chronic condition behaves when you remove the treatment, in the same way blood pressure climbs again when blood-pressure medication stops. Clinicians increasingly view GLP-1 as a long-term tool for a long-term condition.
The honest implication: the question is not only “how much will I lose?” but “what is the plan for keeping it?” A good programme answers that on day one — a maintenance strategy, a step-down approach where appropriate, and the lifestyle structure that does the holding once the medication's role changes.
GLP-1 in Malta: The Local Picture
Malta has among the highest adult obesity rates in the EU, roughly 28%, well above the EU average of around 17%. That is not a story about discipline. It reflects a shift away from the traditional Mediterranean diet, car-dependent towns that strip out incidental movement, and four or five months a year when the heat makes outdoor exercise genuinely hard. The women who come to us are not outliers. They are responding normally to difficult conditions.
On access: the Maltese government has announced a planned scheme to provide GLP-1 medication free to diabetic patients with severe obesity, valued at around €5M and targeting roughly 2,000 patients. It is a welcome step, but it is not yet operational, the tender is still being worked through, and it is limited to a specific patient group. For everyone else, GLP-1 in Malta remains a private, prescription-based treatment.
On cost: pricing depends on the medication, the dose and how long you stay on it, so a clinic should give you an individual breakdown rather than a headline figure. At a free consultation at Carisma Slimming you will leave knowing exactly what you would be paying and why.
FAQs About GLP-1 Weight Loss in Malta
Is GLP-1 safe for weight loss?
GLP-1 medications such as semaglutide and tirzepatide have a strong safety record and have been prescribed for diabetes for over 15 years. They are prescription-only and require a full medical assessment first. The most common side effects are gastrointestinal and usually mild and temporary. Results may vary from person to person.
Who is eligible for GLP-1 weight loss in Malta?
In line with NICE guidance, GLP-1 medication is generally considered for adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as type 2 diabetes, prediabetes or high blood pressure. Eligibility is confirmed only after a doctor reviews your full medical history and current medications. It is not suitable during pregnancy or breastfeeding, or for people with certain thyroid cancer risks.
What are the side effects of GLP-1 medications?
The most common side effects are nausea, constipation, diarrhoea and reduced appetite, particularly in the first few weeks as the dose increases. These usually settle as the body adjusts. Rarer, more serious risks include pancreatitis and gallbladder problems, which is exactly why ongoing medical monitoring is part of a responsible programme rather than an optional extra.
How much weight can you lose on GLP-1?
In clinical trials, semaglutide produced an average of around 15% body-weight reduction and tirzepatide around 20% at the highest dose, over roughly a year of supervised treatment. Real-world results vary widely, and a small proportion of people respond very little even at the maximum dose. These figures are averages from research, not promises any one person will achieve.
Do you regain weight after stopping GLP-1?
Many people regain a meaningful share of the lost weight after stopping. The STEP 1 trial extension found participants regained about two-thirds of their lost weight within a year of stopping the medication. This is why GLP-1 works best inside a structured programme with a maintenance plan, including nutrition and strength training, rather than as a short course taken in isolation.
How much does GLP-1 weight loss cost in Malta?
Cost depends on the medication, the prescribed dose and how long you stay on it, so pricing is given individually after assessment rather than as a single figure. A planned public scheme for diabetic patients with severe obesity has been announced in Malta but is not yet operational. At Carisma Slimming, your consultation includes a clear breakdown of any medication and programme costs before you commit to anything.
You Deserve an Honest Answer, Not a Sales Pitch
If you have read this far, you are not looking for a miracle. You are looking for a path built around your biology instead of blaming you for it. GLP-1 medication can be a genuinely powerful part of that path — for the right person, prescribed properly, and held inside a programme that plans for the long term.
The next step is simple, with no pressure attached to it. Book a free consultation at Carisma Slimming in Floriana. A doctor will review your history, run a body composition assessment, and tell you honestly whether GLP-1 is the right tool for you, or whether something else fits better. You will leave understanding your own body more clearly than you did walking in.
Carisma Slimming, Floriana · Call +356 2780 2062
You did not fail. The plan failed you. Let us build one that does not.
With you every step,
Katya
More from the blog
